| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.848 | 0.002 | 0.848 | Dopamine D1 antagonist | 0.524 0.003 CID_154699734 | ||
| 0.693 | 0.003 | 0.732 | Alpha 2a adrenoreceptor antagonist | 0.732 0.003 CID_154699734 | CID_154699734 | |
| 0.69 | 0.004 | 0.69 | Dopamine antagonist | 0.396 0.008 CID_154699734 | ||
| 0.641 | 0.005 | 0.641 | 5 Hydroxytryptamine antagonist | 0.579 0.005 CID_154699734 | ||
| 0.637 | 0.003 | 0.656 | Alpha 2 adrenoreceptor antagonist | 0.656 0.003 CID_154699734 | CID_154699734 | |
| 0.62 | 0.004 | 0.62 | Alpha adrenoreceptor antagonist | 0.572 0.005 CID_154699734 | ||
| 0.603 | 0.003 | 0.603 | 5 Hydroxytryptamine 1E antagonist | 0.418 0.004 CID_154699734 | ||
| 0.607 | 0.014 | 0.658 | 5 Hydroxytryptamine release stimulant | 0.658 0.01 CID_154699734 | CID_154699734 | |
| 0.595 | 0.003 | 0.595 | Alpha 2b adrenoreceptor antagonist | 0.488 0.004 CID_154699734 | ||
| 0.592 | 0.004 | 0.592 | Dopamine D2 antagonist | 0.361 0.008 CID_154699734 | ||
| 0.585 | 0.004 | 0.601 | 5 Hydroxytryptamine 2B antagonist | 0.601 0.004 CID_154699734 | CID_154699734 | |
| 0.579 | 0.005 | 0.579 | 5 Hydroxytryptamine 2 antagonist | 0.576 0.005 CID_154699734 | ||
| 0.563 | 0.003 | 0.563 | Alpha 2c adrenoreceptor antagonist | 0.416 0.004 CID_154699734 | ||
| 0.56 | 0.004 | 0.56 | 5 Hydroxytryptamine 1F antagonist | 0.467 0.004 CID_154699734 | ||
| 0.553 | 0.004 | 0.577 | 5 Hydroxytryptamine 2C antagonist | 0.577 0.004 CID_154699734 | CID_154699734 | |
| 0.55 | 0.005 | 0.55 | Anesthetic general | 0.389 0.018 CID_154699734 | ||
| 0.561 | 0.017 | 0.561 | Spasmolytic | 0.427 0.035 CID_154699734 | ||
| 0.533 | 0.005 | 0.765 | 5 Hydroxytryptamine agonist | 0.765 0.004 CID_154699734 | CID_154699734 | |
| 0.521 | 0.004 | 0.521 | 5 Hydroxytryptamine 2A antagonist | 0.491 0.005 CID_154699734 | ||
| 0.506 | 0.004 | 0.506 | Dopamine D4 antagonist | 0.194 0.013 CID_154699734 | ||
| 0.501 | 0.005 | 0.501 | Alpha 1 adrenoreceptor antagonist | 0.466 0.005 CID_154699734 | ||
| 0.454 | 0.003 | 0.454 | Dopamine D5 antagonist | 0.254 0.004 CID_154699734 | ||
| 0.454 | 0.006 | 0.472 | Antiadrenergic | 0.472 0.006 CID_154699734 | CID_154699734 | |
| 0.445 | 0.007 | 0.46 | Adrenaline antagonist | 0.46 0.006 CID_154699734 | CID_154699734 | |
| 0.441 | 0.005 | 0.441 | Acetylcholine M1 receptor antagonist | 0.3 0.014 CID_154699734 | ||
| 0.437 | 0.004 | 0.437 | Dopamine D3 antagonist | 0.208 0.01 CID_154699734 | ||
| 0.437 | 0.005 | 0.437 | Alpha 1a adrenoreceptor antagonist | 0.431 0.005 CID_154699734 | ||
| 0.421 | 0.007 | 0.421 | Cholinergic antagonist | 0.357 0.01 CID_154699734 | ||
| 0.415 | 0.007 | 0.415 | Acetylcholine antagonist | 0.352 0.01 CID_154699734 | ||
| 0.411 | 0.006 | 0.411 | 5 Hydroxytryptamine 1 antagonist | 0.233 0.014 CID_154699734 | ||
| 0.442 | 0.044 | 0.442 | GABA C receptor rho-3 antagonist | 0.425 0.051 CID_154699734 | ||
| 0.4 | 0.005 | 0.4 | Alpha 1b adrenoreceptor antagonist | 0.33 0.006 CID_154699734 | ||
| 0.398 | 0.004 | 0.398 | Toll-Like receptor antagonist | 0.369 0.005 CID_154699734 | ||
| 0.39 | 0.004 | 0.39 | Alpha 1 adrenoreceptor agonist | 0.324 0.004 CID_154699734 | ||
| 0.391 | 0.006 | 0.391 | 5 Hydroxytryptamine 1A antagonist | 0.241 0.012 CID_154699734 | ||
| 0.4 | 0.022 | 0.4 | Sigma receptor agonist | 0.251 0.048 CID_154699734 | ||
| 0.428 | 0.056 | 0.668 | Antiobesity | 0.668 0.014 CID_154699734 | CID_154699734 | |
| 0.377 | 0.005 | 0.377 | Histamine H1 receptor antagonist | 0.171 0.019 CID_154699734 | ||
| 0.439 | 0.069 | 0.439 | Analgesic | 0.33 0.12 CID_154699734 | ||
| 0.349 | 0.004 | 0.376 | Alpha adrenoreceptor agonist | 0.376 0.004 CID_154699734 | CID_154699734 | |
| 0.373 | 0.033 | 0.373 | HERG channel blocker | 0.283 0.054 CID_154699734 | ||
| 0.384 | 0.049 | 0.384 | Aldehyde oxidase inhibitor | 0.23 0.09 CID_154699734 | ||
| 0.337 | 0.006 | 0.337 | Nav1.1 sodium channel blocker | 0.323 0.007 CID_154699734 | ||
| 0.332 | 0.007 | 0.332 | Acetylcholine muscarinic antagonist | 0.232 0.018 CID_154699734 | ||
| 0.339 | 0.019 | 0.347 | Tyrosine 3 hydroxylase inhibitor | 0.347 0.017 CID_154699734 | CID_154699734 | |
| 0.306 | 0.004 | 0.306 | 5 Hydroxytryptamine 3 antagonist | 0.176 0.007 CID_154699734 | ||
| 0.302 | 0.005 | 0.302 | 5 Hydroxytryptamine 7 antagonist | 0.222 0.01 CID_154699734 | ||
| 0.3 | 0.01 | 0.3 | Antihistaminic | 0.135 0.037 CID_154699734 | ||
| 0.294 | 0.004 | 0.294 | 5 Hydroxytryptamine 1D antagonist | 0.17 0.009 CID_154699734 | ||
| 0.294 | 0.005 | 0.294 | Dopamine agonist | 0.214 0.009 CID_154699734 | ||
| 0.296 | 0.007 | 0.296 | Mediator release inhibitor | 0.155 0.026 CID_154699734 | ||
| 0.292 | 0.004 | 0.292 | 5 Hydroxytryptamine 5A antagonist | 0.23 0.004 CID_154699734 | ||
| 0.289 | 0.005 | 0.289 | 5 Hydroxytryptamine 1B antagonist | 0.187 0.009 CID_154699734 | ||
| 0.322 | 0.043 | 0.322 | Potassium channel (Voltage-sensitive) blocker | 0.244 0.07 CID_154699734 | ||
| 0.281 | 0.011 | 0.281 | Histamine antagonist | 0.121 0.038 CID_154699734 | ||
| 0.266 | 0.003 | 0.266 | 5 Hydroxytryptamine 3B antagonist | 0.109 0.004 CID_154699734 | ||
| 0.263 | 0.004 | 0.263 | Acetylcholine M5 receptor antagonist | 0.161 0.007 CID_154699734 | ||
| 0.273 | 0.017 | 0.273 | Adenylate cyclase inhibitor | 0.177 0.031 CID_154699734 | ||
| 0.259 | 0.004 | 0.259 | 5 Hydroxytryptamine 5 antagonist | 0.204 0.005 CID_154699734 | ||
| 0.256 | 0.007 | 0.256 | Alpha 1d adrenoreceptor antagonist | 0.201 0.009 CID_154699734 | ||
| 0.243 | 0.004 | 0.52 | 5 Hydroxytryptamine 2 agonist | 0.52 0.002 CID_154699734 | CID_154699734 | |
| 0.284 | 0.047 | 0.293 | Psychostimulant | 0.293 0.044 CID_154699734 | CID_154699734 | |
| 0.254 | 0.02 | 0.254 | Toll-Like receptor 9 antagonist | 0.185 0.043 CID_154699734 | ||
| 0.279 | 0.052 | 0.341 | DNA synthesis inhibitor | 0.341 0.032 CID_154699734 | CID_154699734 | |
| 0.245 | 0.023 | 0.245 | Nav1.2 sodium channel blocker | 0.181 0.042 CID_154699734 | ||
| 0.231 | 0.012 | 0.231 | Nav1.6 sodium channel blocker | 0.181 0.028 CID_154699734 | ||
| 0.358 | 0.139 | 0.364 | Caspase 9 stimulant | 0.364 0.134 CID_154699734 | CID_154699734 | |
| 0.272 | 0.056 | 0.272 | Potassium channel blocker | 0.165 0.12 CID_154699734 | ||
| 0.302 | 0.086 | 0.302 | Vasodilator, coronary | 0.252 0.132 CID_154699734 | ||
| 0.219 | 0.004 | 0.683 | 5 Hydroxytryptamine 2C agonist | 0.683 0.002 CID_154699734 | CID_154699734 | |
| 0.219 | 0.004 | 0.269 | Alpha 2 adrenoreceptor agonist | 0.269 0.004 CID_154699734 | CID_154699734 | |
| 0.274 | 0.06 | 0.274 | 5 Hydroxytryptamine uptake stimulant | 0.262 0.07 CID_154699734 | ||
| 0.224 | 0.018 | 0.224 | Nav1.3 sodium channel blocker | 0.137 0.057 CID_154699734 | ||
| 0.211 | 0.005 | 0.211 | Acetylcholine M4 receptor antagonist | 0.117 0.019 CID_154699734 | ||
| 0.301 | 0.096 | 0.326 | Vasodilator, peripheral | 0.326 0.085 CID_154699734 | CID_154699734 | |
| 0.214 | 0.01 | 0.214 | Protein kinase C zeta inhibitor | 0.195 0.012 CID_154699734 | ||
| 0.277 | 0.078 | 0.277 | Hypoxia-inducible factor 1 alpha inhibitor | 0.269 0.084 CID_154699734 | ||
| 0.277 | 0.082 | 0.28 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.28 0.079 CID_154699734 | CID_154699734 | |
| 0.202 | 0.01 | 0.202 | Creatine kinase inhibitor | 0.166 0.018 CID_154699734 | ||
| 0.199 | 0.007 | 0.199 | Acetylcholine M3 receptor antagonist | 0.164 0.01 CID_154699734 | ||
| 0.204 | 0.012 | 0.227 | Acetylcholine nicotinic antagonist | 0.227 0.01 CID_154699734 | CID_154699734 | |
| 0.191 | 0.005 | 0.191 | Dopamine D2 agonist | 0.133 0.007 CID_154699734 | ||
| 0.195 | 0.018 | 0.204 | MAP3K9 inhibitor | 0.204 0.014 CID_154699734 | CID_154699734 | |
| 0.188 | 0.011 | 0.188 | Prolactin inhibitor | 0.164 0.017 CID_154699734 | ||
| 0.248 | 0.076 | 0.392 | Superoxide dismutase inhibitor | 0.392 0.028 CID_154699734 | CID_154699734 | |
| 0.182 | 0.009 | 0.213 | Neuronal nicotinic receptor antagonist | 0.213 0.008 CID_154699734 | CID_154699734 | |
| 0.212 | 0.041 | 0.212 | Antipruritic | 0.172 0.072 CID_154699734 | ||
| 0.181 | 0.011 | 0.195 | Estrogen receptor beta antagonist | 0.195 0.01 CID_154699734 | CID_154699734 | |
| 0.185 | 0.015 | 0.198 | Estrogen antagonist | 0.198 0.013 CID_154699734 | CID_154699734 | |
| 0.211 | 0.04 | 0.211 | Diuretic | 0.134 0.091 CID_154699734 | ||
| 0.177 | 0.008 | 0.177 | Dopamine uptake inhibitor | 0.086 0.023 CID_154699734 | ||
| 0.211 | 0.042 | 0.211 | Cholinergic | 0.204 0.044 CID_154699734 | ||
| 0.18 | 0.019 | 0.18 | Protein kinase C gamma inhibitor | 0.173 0.021 CID_154699734 | ||
| 0.298 | 0.137 | 0.318 | MAP kinase kinase 6 inhibitor | 0.318 0.119 CID_154699734 | CID_154699734 | |
| 0.177 | 0.019 | 0.177 | Acetylcholine agonist | 0.169 0.021 CID_154699734 | ||
| 0.168 | 0.012 | 0.2 | Acetylcholine nicotinic agonist | 0.2 0.008 CID_154699734 | CID_154699734 | |
| 0.158 | 0.005 | 0.348 | 5 Hydroxytryptamine 2A agonist | 0.348 0.003 CID_154699734 | CID_154699734 | |
| 0.158 | 0.01 | 0.158 | Acetylcholine M2 receptor antagonist | 0.089 0.025 CID_154699734 | ||
| 0.23 | 0.082 | 0.23 | Vasodilator | 0.215 0.093 CID_154699734 | ||
| 0.172 | 0.025 | 0.186 | 5 Hydroxytryptamine 3A agonist | 0.186 0.02 CID_154699734 | CID_154699734 | |
| 0.216 | 0.073 | 0.216 | ErbB-1 antagonist | 0.169 0.134 CID_154699734 | ||
| 0.158 | 0.015 | 0.172 | 5 Hydroxytryptamine uptake inhibitor | 0.172 0.013 CID_154699734 | CID_154699734 | |
| 0.268 | 0.126 | 0.323 | Calcium channel activator | 0.323 0.07 CID_154699734 | CID_154699734 | |
| 0.151 | 0.014 | 0.151 | 5 Hydroxytryptamine 1 agonist | 0.068 0.029 CID_154699734 | ||
| 0.184 | 0.048 | 0.184 | Protein kinase stimulant | 0.123 0.09 CID_154699734 | ||
| 0.138 | 0.008 | 0.138 | 5 Hydroxytryptamine 6 antagonist | 0.138 0.008 CID_154699734 | ||
| 0.145 | 0.017 | 0.145 | Opioid kappa receptor antagonist | 0.116 0.025 CID_154699734 | ||
| 0.136 | 0.011 | 0.15 | Adrenaline uptake inhibitor | 0.15 0.009 CID_154699734 | CID_154699734 | |
| 0.131 | 0.009 | 0.143 | Toll-Like receptor 7 antagonist | 0.143 0.007 CID_154699734 | CID_154699734 | |
| 0.212 | 0.09 | 0.212 | MAP-kinase-activated kinase 5 inhibitor | 0.198 0.105 CID_154699734 | ||
| 0.126 | 0.005 | 0.126 | 5 Hydroxytryptamine 7 agonist | 0.112 0.005 CID_154699734 | ||
| 0.288 | 0.168 | 0.397 | Calcium channel L-type activator | 0.397 0.083 CID_154699734 | CID_154699734 | |
| 0.135 | 0.014 | 0.161 | Estrogen receptor alpha antagonist | 0.161 0.01 CID_154699734 | CID_154699734 | |
| 0.141 | 0.024 | 0.141 | Acetylcholine M3 receptor agonist | 0.1 0.045 CID_154699734 | ||
| 0.117 | 0.003 | 0.117 | Adenylate cyclase 1 inhibitor | 0.09 0.005 CID_154699734 | ||
| 0.152 | 0.039 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.131 0.116 CID_154699734 | ||
| 0.14 | 0.029 | 0.14 | Opioid antagonist | 0.124 0.035 CID_154699734 | ||
| 0.128 | 0.017 | 0.128 | Histamine H2 receptor antagonist | 0.09 0.046 CID_154699734 | ||
| 0.115 | 0.01 | 0.115 | Nicotinic receptor alpha7 subunit antagonist | 0.105 0.011 CID_154699734 | ||
| 0.114 | 0.009 | 0.114 | Protein kinase C beta inhibitor | 0.109 0.01 CID_154699734 | ||
| 0.191 | 0.089 | 0.191 | Antimitotic | 0.143 0.128 CID_154699734 | ||
| 0.125 | 0.023 | 0.179 | Adrenaline agonist | 0.179 0.009 CID_154699734 | CID_154699734 | |
| 0.112 | 0.011 | 0.112 | 5 Hydroxytryptamine 3A antagonist | 0.091 0.022 CID_154699734 | ||
| 0.103 | 0.005 | 0.103 | Histamine H4 receptor antagonist | 0.07 0.012 CID_154699734 | ||
| 0.1 | 0.007 | 0.1 | 5 Hydroxytryptamine 4 antagonist | 0.065 0.02 CID_154699734 | ||
| 0.108 | 0.015 | 0.108 | Protein kinase C eta inhibitor | 0.088 0.02 CID_154699734 | ||
| 0.217 | 0.124 | 0.217 | Gastrin inhibitor | |||
| 0.111 | 0.023 | 0.152 | Nicotinic alpha4beta2 receptor antagonist | 0.152 0.008 CID_154699734 | CID_154699734 | |
| 0.153 | 0.066 | 0.171 | Lipid peroxidase inhibitor | 0.171 0.055 CID_154699734 | CID_154699734 | |
| 0.114 | 0.027 | 0.114 | Opioid mu receptor antagonist | 0.097 0.033 CID_154699734 | ||
| 0.101 | 0.014 | 0.101 | Dopamine D4 agonist | 0.056 0.03 CID_154699734 | ||
| 0.115 | 0.03 | 0.115 | Phosphodiesterase 6D inhibitor | |||
| 0.126 | 0.041 | 0.126 | Bronchodilator | 0.109 0.054 CID_154699734 | ||
| 0.1 | 0.015 | 0.1 | 5 Hydroxytryptamine 3 agonist | 0.082 0.025 CID_154699734 | ||
| 0.213 | 0.131 | 0.236 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.236 0.086 CID_154699734 | CID_154699734 | |
| 0.088 | 0.007 | 0.088 | Prolactin release inhibitor | 0.083 0.009 CID_154699734 | ||
| 0.089 | 0.018 | 0.089 | 5 Hydroxytryptamine 1A agonist | 0.065 0.024 CID_154699734 | ||
| 0.086 | 0.015 | 0.086 | Dopamine transporter inhibitor | 0.062 0.024 CID_154699734 | ||
| 0.102 | 0.031 | 0.254 | NMDA 2 receptor antagonist | 0.254 0.006 CID_154699734 | CID_154699734 | |
| 0.119 | 0.048 | 0.135 | Chemokine receptor antagonist | 0.135 0.039 CID_154699734 | CID_154699734 | |
| 0.085 | 0.018 | 0.107 | Nicotinic neuronal receptor agonist | 0.107 0.011 CID_154699734 | CID_154699734 | |
| 0.108 | 0.042 | 0.218 | NMDA receptor antagonist | 0.218 0.012 CID_154699734 | CID_154699734 | |
| 0.072 | 0.008 | 0.149 | Dopamine D5 agonist | 0.149 0.003 CID_154699734 | CID_154699734 | |
| 0.171 | 0.107 | 0.171 | Anticonvulsant | |||
| 0.169 | 0.107 | 0.169 | Platelet aggregation inhibitor | 0.168 0.108 CID_154699734 | ||
| 0.088 | 0.028 | 0.104 | MAP kinase kinase 7 inhibitor | 0.104 0.01 CID_154699734 | CID_154699734 | |
| 0.076 | 0.016 | 0.076 | Acetylcholine M2 receptor agonist | 0.066 0.023 CID_154699734 | ||
| 0.143 | 0.083 | 0.155 | GABA C receptor rho-2 antagonist | 0.155 0.068 CID_154699734 | CID_154699734 | |
| 0.091 | 0.032 | 0.091 | Opioid delta receptor antagonist | 0.09 0.033 CID_154699734 | ||
| 0.122 | 0.065 | 0.147 | Topoisomerase II inhibitor | 0.147 0.051 CID_154699734 | CID_154699734 | |
| 0.092 | 0.036 | 0.092 | Analgesic, opioid | 0.076 0.052 CID_154699734 | ||
| 0.058 | 0.004 | 0.068 | Nicotinic alpha3beta4 receptor agonist | 0.068 0.004 CID_154699734 | CID_154699734 | |
| 0.082 | 0.032 | 0.082 | Acetylcholine M5 receptor agonist | |||
| 0.137 | 0.088 | 0.152 | NOS3 expression enhancer | 0.152 0.071 CID_154699734 | CID_154699734 | |
| 0.061 | 0.014 | 0.086 | Kinesin antagonist | 0.086 0.01 CID_154699734 | CID_154699734 | |
| 0.061 | 0.014 | 0.086 | Kinesin-like protein 1 inhibitor | 0.086 0.01 CID_154699734 | CID_154699734 | |
| 0.106 | 0.059 | 0.106 | Platelet activating factor beta antagonist | |||
| 0.09 | 0.043 | 0.09 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.106 | 0.061 | 0.109 | Toll-Like receptor 4 antagonist | 0.109 0.056 CID_154699734 | CID_154699734 | |
| 0.123 | 0.079 | 0.123 | NADPH oxidase inhibitor | 0.119 0.084 CID_154699734 | ||
| 0.065 | 0.022 | 0.065 | 5 Hydroxytryptamine 1B agonist | 0.054 0.035 CID_154699734 | ||
| 0.058 | 0.015 | 0.058 | Dopamine D3 agonist | 0.046 0.022 CID_154699734 | ||
| 0.093 | 0.051 | 0.093 | Bromodomain-containing protein 2 inhibitor | |||
| 0.109 | 0.068 | 0.109 | Acetylcholine release stimulant | |||
| 0.069 | 0.029 | 0.069 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.058 0.047 CID_154699734 | ||
| 0.177 | 0.137 | 0.177 | DNA damaging | 0.169 0.147 CID_154699734 | ||
| 0.068 | 0.028 | 0.068 | Acetylcholine muscarinic agonist | |||
| 0.07 | 0.031 | 0.078 | Cyclin-dependent kinase 6 inhibitor | 0.078 0.023 CID_154699734 | CID_154699734 | |
| 0.086 | 0.047 | 0.09 | CC chemokine 5 receptor agonist | 0.09 0.037 CID_154699734 | CID_154699734 | |
| 0.251 | 0.213 | 0.251 | Apoptosis agonist | |||
| 0.108 | 0.072 | 0.108 | Platelet activating factor antagonist | |||
| 0.085 | 0.049 | 0.116 | Glycine receptor antagonist | 0.116 0.02 CID_154699734 | CID_154699734 | |
| 0.068 | 0.032 | 0.068 | Androgen agonist | 0.06 0.041 CID_154699734 | ||
| 0.041 | 0.005 | 0.041 | Estrogen-related receptor gamma antagonist | 0.032 0.012 CID_154699734 | ||
| 0.096 | 0.061 | 0.147 | Protein kinase C mu inhibitor | 0.147 0.027 CID_154699734 | CID_154699734 | |
| 0.103 | 0.068 | 0.103 | Topoisomerase I inhibitor | 0.103 0.068 CID_154699734 | ||
| 0.043 | 0.009 | 0.043 | Estrogen-related receptor beta antagonist | 0.041 0.01 CID_154699734 | ||
| 0.048 | 0.015 | 0.187 | 5 Hydroxytryptamine 2B agonist | 0.187 0.003 CID_154699734 | CID_154699734 | |
| 0.134 | 0.101 | 0.134 | Heat shock protein 70 antagonist | |||
| 0.092 | 0.059 | 0.092 | Thioredoxin inhibitor | |||
| 0.114 | 0.084 | 0.167 | Cyclooxygenase 3 inhibitor | 0.167 0.035 CID_154699734 | CID_154699734 | |
| 0.04 | 0.009 | 0.04 | Protein kinase C beta I inhibitor | 0.037 0.014 CID_154699734 | ||
| 0.084 | 0.054 | 0.085 | ALK inhibitor | 0.085 0.053 CID_154699734 | CID_154699734 | |
| 0.049 | 0.02 | 0.049 | Nerve growth factor antagonist | |||
| 0.084 | 0.055 | 0.084 | Estrogen-related receptor beta agonist | 0.078 0.076 CID_154699734 | ||
| 0.064 | 0.035 | 0.064 | Potassium channel (Ca-activated) blocker | 0.058 0.046 CID_154699734 | ||
| 0.057 | 0.03 | 0.057 | Sigma receptor antagonist | |||
| 0.054 | 0.027 | 0.095 | Nicotinic receptor alpha4 subunit antagonist | 0.095 0.009 CID_154699734 | CID_154699734 | |
| 0.102 | 0.075 | 0.102 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.078 | 0.052 | 0.078 | MAP kinase 7 inhibitor | |||
| 0.036 | 0.01 | 0.048 | Nicotinic alpha4beta2 receptor agonist | 0.048 0.005 CID_154699734 | CID_154699734 | |
| 0.16 | 0.135 | 0.16 | Cyclic AMP phosphodiesterase inhibitor | 0.159 0.137 CID_154699734 | ||
| 0.055 | 0.031 | 0.055 | CC chemokine 5 receptor antagonist | 0.049 0.037 CID_154699734 | ||
| 0.056 | 0.035 | 0.056 | Nicotinic alpha7 receptor agonist | |||
| 0.099 | 0.078 | 0.099 | Cystathionine beta-synthase inhibitor | |||
| 0.067 | 0.048 | 0.067 | Glutamate (mGluR7) antagonist | |||
| 0.066 | 0.047 | 0.066 | Bcl2 antagonist | |||
| 0.053 | 0.034 | 0.053 | Estrogen agonist | 0.052 0.034 CID_154699734 | ||
| 0.063 | 0.046 | 0.081 | Beta 3 adrenoreceptor antagonist | 0.081 0.022 CID_154699734 | CID_154699734 | |
| 0.198 | 0.181 | 0.198 | Apoptosis antagonist | |||
| 0.08 | 0.065 | 0.09 | Antineoplastic alkaloid | 0.09 0.055 CID_154699734 | CID_154699734 | |
| 0.04 | 0.024 | 0.04 | 5-Alpha-reductase inhibitor | |||
| 0.045 | 0.029 | 0.056 | Nicotinic receptor alpha3 subunit antagonist | 0.056 0.021 CID_154699734 | CID_154699734 | |
| 0.044 | 0.029 | 0.044 | Opioid kappa receptor agonist | |||
| 0.034 | 0.019 | 0.034 | Acetylcholine M4 receptor agonist | |||
| 0.026 | 0.012 | 0.026 | Dopamine D1 agonist | 0.024 0.014 CID_154699734 | ||
| 0.091 | 0.077 | 0.135 | GABA C receptor rho-1 antagonist | 0.135 0.029 CID_154699734 | CID_154699734 | |
| 0.03 | 0.017 | 0.033 | 5 Hydroxytryptamine 6 agonist | 0.033 0.013 CID_154699734 | CID_154699734 | |
| 0.057 | 0.044 | 0.114 | CXC chemokine 4 receptor antagonist | 0.114 0.021 CID_154699734 | CID_154699734 | |
| 0.033 | 0.021 | 0.037 | Protein kinase C beta II inhibitor | 0.037 0.014 CID_154699734 | CID_154699734 | |
| 0.079 | 0.067 | 0.104 | Histamine N-methyltransferase inhibitor | 0.104 0.043 CID_154699734 | CID_154699734 | |
| 0.045 | 0.034 | 0.045 | Opioid mu receptor agonist | |||
| 0.05 | 0.04 | 0.05 | Opioid agonist | 0.048 0.042 CID_154699734 | ||
| 0.018 | 0.009 | 0.045 | Nicotinic alpha4 receptor agonist | 0.045 0.004 CID_154699734 | CID_154699734 | |
| 0.027 | 0.018 | 0.027 | Sigma 2 receptor antagonist | |||
| 0.139 | 0.131 | 0.195 | Phospholipase C inhibitor | 0.195 0.047 CID_154699734 | CID_154699734 | |
| 0.148 | 0.141 | 0.148 | Neurotrophic factor enhancer | |||
| 0.031 | 0.023 | 0.031 | Estrogen receptor beta agonist | 0.027 0.024 CID_154699734 | ||
| 0.12 | 0.114 | 0.125 | Heat shock protein 90 antagonist | 0.125 0.105 CID_154699734 | CID_154699734 | |
| 0.019 | 0.013 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 CID_154699734 | ||
| 0.04 | 0.034 | 0.063 | NMDA receptor subunit 3B antagonist | 0.063 0.018 CID_154699734 | CID_154699734 | |
| 0.044 | 0.04 | 0.044 | Phosphodiesterase 6C inhibitor | |||
| 0.123 | 0.12 | 0.123 | Pregnane X receptor agonist | |||
| 0.096 | 0.093 | 0.096 | Alkylator | |||
| 0.163 | 0.161 | 0.17 | 5 Hydroxytryptamine 3E antagonist | 0.17 0.134 CID_154699734 | CID_154699734 | |
| 0.041 | 0.039 | 0.041 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.014 | 0.012 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 CID_154699734 | ||
| 0.045 | 0.043 | 0.074 | Topoisomerase II beta inhibitor | 0.074 0.015 CID_154699734 | CID_154699734 | |
| 0.037 | 0.036 | 0.037 | Acetylcholine M1 receptor agonist | |||
| 0.048 | 0.047 | 0.061 | NMDA 2B receptor antagonist | 0.061 0.031 CID_154699734 | CID_154699734 | |
| 0.028 | 0.028 | 0.032 | Estrogen receptor alpha agonist | 0.032 0.025 CID_154699734 | CID_154699734 | |
| 0.121 | 0.122 | 0.141 | Adenylate cyclase stimulant | 0.141 0.079 CID_154699734 | CID_154699734 | |
| 0.119 | 0.12 | 0.12 | Hexokinase inhibitor | 0.12 0.119 CID_154699734 | CID_154699734 | |
| 0.122 | 0.124 | 0.142 | Heat shock protein 90 alpha antagonist | 0.142 0.096 CID_154699734 | CID_154699734 | |
| 0.064 | 0.068 | 0.074 | Glycine receptor agonist | 0.074 0.048 CID_154699734 | CID_154699734 | |
| 0.052 | 0.057 | 0.084 | NMDA 2C receptor antagonist | 0.084 0.022 CID_154699734 | CID_154699734 | |
| 0.044 | 0.051 | 0.058 | Toll-Like receptor 8 antagonist | 0.058 0.033 CID_154699734 | CID_154699734 | |
| 0.027 | 0.04 | 0.049 | NMDA receptor subunit 3A antagonist | 0.049 0.02 CID_154699734 | CID_154699734 | |
| 0.07 | 0.092 | 0.099 | Protein kinase C delta inhibitor | 0.099 0.053 CID_154699734 | CID_154699734 | |
| 0.055 | 0.078 | 0.075 | CXC chemokine receptor antagonist | 0.075 0.043 CID_154699734 | CID_154699734 | |
| 0.147 | 0.17 | 0.168 | Interleukin agonist | 0.168 0.151 CID_154699734 | CID_154699734 | |
| 0.083 | 0.11 | 0.136 | GABA C receptor antagonist | 0.136 0.038 CID_154699734 | CID_154699734 | |
| 0.031 | 0.058 | 0.055 | Phenylethanolamine N methyltransferase inhibitor | 0.055 0.01 CID_154699734 | CID_154699734 | |
| 0.076 | 0.105 | 0.113 | Nitric-oxide synthase inhibitor | 0.113 0.043 CID_154699734 | CID_154699734 | |
| 0.027 | 0.067 | 0.09 | NMDA 2A receptor antagonist | 0.09 0.016 CID_154699734 | CID_154699734 | |
| 0.049 | 0.091 | 0.063 | Protein kinase C alpha inhibitor | 0.063 0.054 CID_154699734 | CID_154699734 | |
| 0.045 | 0.093 | 0.083 | Check point kinase 1 inhibitor | 0.083 0.037 CID_154699734 | CID_154699734 | |
| 0.08 | 0.129 | 0.094 | DOPA decarboxylase inhibitor | 0.094 0.088 CID_154699734 | CID_154699734 | |
| 0.124 | 0.181 | 0.15 | Neurotensin receptor agonist | 0.15 0.102 CID_154699734 | CID_154699734 | |
| 0.218 | 0.277 | 0.279 | 5 Hydroxytryptamine release inhibitor | 0.279 0.19 CID_154699734 | CID_154699734 | |
| 0.042 | 0.103 | 0.059 | Cyclin B3 inhibitor | 0.059 0.058 CID_154699734 | CID_154699734 | |
| 0.077 | 0.147 | 0.103 | Alpha-N-acetylglucosaminidase inhibitor | 0.103 0.098 CID_154699734 | CID_154699734 | |
| 0.04 | 0.111 | 0.072 | Beta adrenoreceptor antagonist | 0.072 0.036 CID_154699734 | CID_154699734 | |
| 0.181 | 0.253 | 0.239 | Antibacterial | 0.239 0.187 CID_154699734 | CID_154699734 | |
| 0.026 | 0.103 | 0.053 | Beta 2 adrenoreceptor antagonist | 0.053 0.033 CID_154699734 | CID_154699734 | |
| 0.061 | 0.14 | 0.132 | GABA C receptor agonist | 0.132 0.042 CID_154699734 | CID_154699734 | |
| 0.025 | 0.122 | 0.059 | Beta 1 adrenoreceptor antagonist | 0.059 0.036 CID_154699734 | CID_154699734 | |
| 0.023 | 0.12 | 0.046 | Poly(ADP-ribose) polymerase inhibitor | 0.046 0.029 CID_154699734 | CID_154699734 | |
| 0.035 | 0.136 | 0.077 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.077 0.052 CID_154699734 | CID_154699734 | |
| 0.044 | 0.162 | 0.099 | MAP-kinase-activated kinase inhibitor | 0.099 0.04 CID_154699734 | CID_154699734 | |
| 0.015 | 0.135 | 0.034 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.034 0.033 CID_154699734 | CID_154699734 | |
| 0.024 | 0.164 | 0.052 | Purinergic P2X4 antagonist | 0.052 0.022 CID_154699734 | CID_154699734 | |
| 0.042 | 0.185 | 0.081 | Inducible nitric-oxide synthase inhibitor | 0.081 0.06 CID_154699734 | CID_154699734 | |
| 0.031 | 0.195 | 0.082 | MAP-kinase-activated kinase 2 inhibitor | 0.082 0.042 CID_154699734 | CID_154699734 | |
| 0.026 | 0.22 | 0.071 | Phospholipase D inhibitor | 0.071 0.05 CID_154699734 | CID_154699734 | |
| 0.149 | 0.362 | 0.249 | Cyclophilin D inhibitor | 0.249 0.214 CID_154699734 | CID_154699734 | |
| 0.015 | 0.539 | 0.042 | Alpha 1L adrenoreceptor agonist | 0.042 0.034 CID_154699734 | CID_154699734 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |